Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Quentin30on Nov 07, 2024 1:45pm
120 Views
Post# 36301499

1 year on

1 year onJust over a year ago I decided to sell out of my ONCY position, and trade back my losses elsewhere... Getting out at CA$2.07 wasn't ideal, as in 2023, we'd seen over 4 bucks... I was down about a third from my breakeven after 20 years

In that time ONCY has cratered, and stayed down... the so-called inflection points have come and gone... the mBC data is complete... but where are the investors... where is the partner..? Where is the CEO ??

In the meantime I invested in BTC, CRSP, TSLA and traded a handful of other stocks... I'm happy that I've almost tripled the value of my investments in that time, but had I held onto ONCY, I would still be down something 40+%.

So for those of you who watch and wait for the big payoff, do take note that the rest of the market has been leaving the station for some time... 

Even the analysts are only indicating a price target of $5 US or so, which is just over a 3x from here... why take the risk in this POS, which after 10+ years of "talking to big pharma" still seems as far away from a partner and approval than ever. If you have no money to run a Phase II to get you to Accelerated Approval, what is ONCY worth ?  and the parternship with Adlai Nortye is meaningless...

ONCY is running out of cash... don't be holding the bag when it implodes... sell half, buy Tesla and see your money double in a year. Just sayin'
<< Previous
Bullboard Posts
Next >>